Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the "Compassionate" Use Phase

NCT06913634 is registered in ClinicalTrials.gov with Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia as lead sponsor.

NCT NCT06913634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06913634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the "Compassionate" Use Phase
Lead sponsor
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
Phase
Observational
Overall status
Active, not recruiting
Start date
May 30, 2023
Completion date
June 30, 2026
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia major